Alvea LLC


Alvea is a biotechnology startup dedicated to stopping future pandemics in their tracks. Alvea is dedicated to building technology that can deliver inhaled, shelf-stable RNA therapies and vaccines that patients can self-administer as easily as an inhaler. Using its technology, Alvea is actively developing a pan-variant COVID vaccine that’s dramatically easier to calibrate to new pathogens, manufacture, ship, and administer than anything that’s currently available for strengthening public health in an emergency.